The Effects of the Baltimore Bridge Collapse is Testing the Resilience of the Supply Chain

Designed Conveyor Systems Banner ad

 

As one of the busiest ports in the United States continues to grapple with the aftermath of the Francis Scott Key Bridge collapse, the ripple effects on global supply chains are profound and widespread. The tragic incident not only disrupted local operations but has also spotlighted vulnerabilities in supply chain resilience globally. 

The bridge, which was pivotal for trade, may take a decade and billions to rebuild. In turn, this is posing some serious questions about the long-term economic impacts and other strategies for mitigation. While there has been some progress as the first cargo ship finally passed through the channel last week, along with efforts to reroute, that is a small dent compared to what the port normally sustained.

What strategies can industries employ to adapt and strengthen supply chain resilience in the face of such significant disruptions? Several experts shared their insights examining that.

On the latest segment of “Experts Talk,” host and the Voice of B2B, Daniel Litwin, engaged in a conversation about the Baltimore bridge collapse with Chris Timmer, CEO of Linnworks, Harrison Crabtree, Director at the World Trade Center New Orleans, and Dr. Piyush Shah, Assistant Professor of Supply Chain Management at Florida Gulf Coast University. They explored the immediate and long-term consequences of the collapse impacting global supply chains, strategic responses, and they analyzed the broader implications for trade and industry.

A few key points of their discussion:

  • The role of the Port of Baltimore in global logistics and the immediate impacts of its closure.
  • Strategies for mitigating risks and enhancing supply chain resilience in light of recent disruptions.
  • The future of global trade and logistics in an era marked by frequent, significant disruptions.

Chris Timmer is the CEO of Linnworks, a company specializing in inventory management solutions. He has a background in logistics and technology, leading initiatives that enhance efficiency and connectivity across global supply chains.

Harrison Crabtree serves as the Director of the World Trade Center New Orleans. His expertise in global trade and economic development has positioned him as a key player in regional and international logistics discussions.

Dr. Piyush Shah is an Assistant Professor of Supply Chain Management at Florida Gulf Coast University. His academic and professional work focuses on supply chain resilience, risk management, and the intersection of technology and logistics.

Article by Alexandra Simon.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More